How long does 4-AcO-DiPT last?

The total duration of 4-AcO-DiPT via oral is 3 hours to 4 hours. Onset typically occurs within 15 minutes to 40 minutes. Peak effects last 1.5 hours to 2 hours.

4-AcO-DiPT — SubstanceWiki

4-AcO-DiPT (4-acetoxy-N,N-diisopropyltryptamine), also known as iprocetyl or 4-acetoxy-DiPT, is a synthetic psychedelic tryptamine and acetylated prodrug analog of 4-HO-DiPT (iprocin). It belongs to the same structural family as psilocybin but substitutes two isopropyl groups on the terminal amine rather than two methyl groups. The compound was first synthesized and documented by Alexander Shulgin and Ann Shulgin, with their research recorded in the 1997 book TiHKAL: Tryptamines I Have Known and Loved.

4-AcO-DiPT is considered by many experienced tryptamine users to have a notably distinct character within the psychedelic tryptamine class. Community reports and Shulgin's own documentation describe an experience that is more physical, erotic, and sensory than the archetypal psilocybin-like 4-AcO-DMT — with less pronounced visual geometry but heightened tactile and bodily sensation, euphoria, and sensory enhancement. Users frequently note a particularly pronounced effect on music perception and a warm, stimulating quality. Duration is relatively short — typically 3–4 hours — making it one of the briefer full-spectrum psychedelic tryptamines.

The name "iprocin" for its active form (4-HO-DiPT) alludes to the isopropyl substitution pattern. Unlike the DMT analog 4-AcO-DMT, which is widely available and well documented, 4-AcO-DiPT is considerably more obscure in the research chemical market, though it maintains a following among tryptamine connoisseurs for its distinctive profile.

How It Feels

The onset of 4-AcO-DiPT announces itself through the ears before the eyes. Within thirty to forty-five minutes of ingestion, a subtle shift in auditory perception begins — a faint metallic quality creeps into familiar sounds, as though they are being played through a slightly warped speaker. Voices acquire an unusual resonance, and ambient noise takes on a layered, almost musical structure. Concurrently, a mild body buzz emerges, concentrated in the torso and hands, accompanied by a light-headed spaciness that is neither pleasant nor unpleasant but distinctly strange.

As the experience deepens, the auditory effects become the defining feature. Pitch shifts begin: voices drop or rise by a semitone or two, music starts to sound slightly off-key in ways that are simultaneously disorienting and fascinating. Familiar songs become alien compositions, their melodies recognizable but transformed, as though being performed by entirely different instruments in a slightly different tuning system. Conversations take on a surreal quality — the words are comprehensible, but they arrive with an unfamiliar timbre, making even intimate voices sound as though they belong to strangers. Visually, the effects are moderate: soft color enhancement, gentle surface breathing, and occasional tracers behind moving objects, but the visual dimension plays second fiddle to what is happening in the auditory landscape.

The peak arrives around ninety minutes to two hours in and holds for roughly two to three hours. The body load can be significant — a heavy, somewhat uncomfortable pressure in the chest and stomach, accompanied by vasoconstriction that leaves the extremities cold. Temperature regulation becomes erratic; waves of warmth alternate with sudden chills. The headspace is introspective but can be difficult to navigate, as the persistent auditory distortion creates an undercurrent of strangeness that colors every thought. Some find this dissonance fascinating and thought-provoking; others find it unsettling, particularly when trying to communicate.

Coming down, the auditory distortions gradually fade, the last to leave being that faint metallic sheen on voices. The body relaxes, the cold extremities warm, and a drowsy calm replaces the tension of the peak. The overall experience leaves behind a peculiar sense of having heard the world from a vantage point that does not normally exist — as though the usual frequency at which reality broadcasts had been briefly shifted to an adjacent channel.

Subjective Effects

The effects listed below are based on the Subjective Effect Index (SEI), an open research literature based on anecdotal reports and personal analyses. They should be viewed with a healthy degree of skepticism. These effects will not necessarily occur in a predictable or reliable manner, although higher doses are more liable to induce the full spectrum of effects.

Physical Effects

Physical(13)

Body load— A diffuse, heavy physical discomfort involving tension, pressure, and malaise in the torso and limbs...
Excessive yawning— Involuntary, repeated yawning that occurs far more frequently than normal and often without the usua...
Increased heart rate— A noticeable acceleration of heartbeat that can range from a subtle awareness of one's pulse to a fo...
Increased libido— A marked enhancement of sexual desire, arousal, and sensitivity to erotic stimuli that can range fro...
Muscle relaxation— The experience of muscles throughout the body losing their rigidity and tension, becoming noticeably...
Nausea— An uncomfortable sensation of queasiness and stomach discomfort that may or may not lead to vomiting...
Physical euphoria— An intensely pleasurable bodily sensation that can manifest as waves of warmth, tingling electricity...
Pupil dilation— A visible enlargement of the pupil diameter (mydriasis) that can range from subtle widening to drama...
Sedation— A state of deep physical and mental calming that manifests as a progressive desire to remain still, ...
Seizure— Uncontrolled brain electrical activity causing convulsions and loss of consciousness -- a life-threa...
Stimulation— A state of heightened physical and mental energy characterized by increased wakefulness, elevated mo...
Vasoconstriction— A narrowing of blood vessels throughout the body that produces sensations of cold extremities, tingl...
Watery eyes— Excessive tear production causing overflow tearing and blurred vision, commonly occurring during opi...

Tactile(1)

Tactile enhancement— The sense of touch becomes dramatically heightened, making physical contact feel intensely pleasurab...

Cognitive & Perceptual Effects

Visual(6)

Colour enhancement— An intensification of the brightness, vividness, and saturation of colors in the external environmen...
Colour shifting— The visual experience of colors on objects and surfaces cycling through continuous, fluid transforma...
Drifting— The visual experience of perceiving stationary objects, textures, and surfaces as appearing to flow,...
Geometry— The experience of perceiving complex, ever-shifting geometric patterns superimposed over the visual ...
Tracers— Moving objects leave visible trails of varying length and opacity behind them, similar to long-expos...
Visual acuity enhancement— Vision becomes sharper and more defined than normal, as though a slightly blurry lens has been broug...

Detection Methods

Urine Detection

4-AcO-DiPT is not targeted by standard immunoassay-based urine drug screens. As a prodrug, 4-AcO-DiPT is rapidly hydrolyzed in vivo to its corresponding 4-HO (psilocin-type) metabolite, and it is primarily this metabolite that would be detected in biological specimens. Specialized LC-MS/MS methods can detect 4-substituted tryptamine metabolites in urine for approximately 24 to 48 hours after ingestion. The detection window is relatively short compared to many other drug classes due to the rapid hepatic metabolism and renal clearance of tryptamine compounds. Psilocin (4-HO-DMT) is the most commonly targeted analyte in specialized tryptamine panels, and structural analogs may or may not be captured depending on the specific method.

Blood and Serum Detection

Blood detection windows for 4-AcO-DiPT are short, typically 4 to 12 hours after oral ingestion. Peak plasma concentrations of the active metabolite occur within 1 to 2 hours. The rapid first-pass metabolism means that parent compound concentrations in blood are often negligible for 4-AcO prodrugs, while 4-HO compounds themselves are measured directly. LC-MS/MS is required for reliable serum detection at the low concentrations involved.

Standard Drug Panel Inclusion

4-AcO-DiPT is NOT included on standard 5-panel, 10-panel, or 12-panel drug screens. Tryptamines do not cross-react with immunoassay targets for any of the standard panel analytes (amphetamines, cannabinoids, cocaine metabolites, opiates, PCP, benzodiazepines, or barbiturates). Detection requires a specific request for tryptamine or novel psychoactive substance testing at a reference laboratory. Some extended forensic panels include psilocin, which may capture certain 4-substituted tryptamines, but this coverage is not guaranteed for all structural variants.

Confirmatory Methods

Confirmatory identification of 4-AcO-DiPT relies on LC-MS/MS with reference standards specific to the compound or its expected metabolites. GC-MS can also be used following appropriate derivatization. Immunoassay-based methods for psilocybin and psilocin exist but show variable cross-reactivity with structural analogs and are not considered reliable for novel 4-substituted tryptamines. Reference laboratories specializing in novel psychoactive substances offer the most comprehensive detection capabilities.

Reagent Testing (Harm Reduction)

The Ehrlich reagent is the primary harm reduction tool for 4-AcO-DiPT. A sample placed on the reagent should produce a purple to violet color change, confirming the presence of an indole ring system characteristic of tryptamines. This reaction is shared with LSD, psilocybin, DMT, and all indole-containing compounds, so it confirms the general class but not the specific identity. The Hofmann reagent provides a confirmatory blue to violet reaction for tryptamines. The Marquis reagent typically shows no reaction or a dark brown discoloration with 4-substituted tryptamines. A positive Ehrlich result significantly reduces the probability that the substance is a dangerous substitute such as an NBOMe compound.

Interactions

Substance	Status	Note
3-FMA	Caution	Increases anxiety, cardiovascular stress, and psychological intensity
4-MMC	Caution	Increases anxiety, cardiovascular stress, and psychological intensity
8-Chlorotheophylline	Caution	Increases anxiety, cardiovascular stress, and psychological intensity
Adrafinil	Caution	Increases anxiety, cardiovascular stress, and psychological intensity
Anandamide	Caution	Cannabis can unpredictably intensify psychedelic effects and increase anxiety
APICA	Caution	Cannabis can unpredictably intensify psychedelic effects and increase anxiety
Atropa belladonna	Caution	Unpredictable compounding of hallucinogenic effects with anticholinergic delirium
Benzydamine	Caution	Increases anxiety, cardiovascular stress, and psychological intensity
Bromantane	Caution	Increases anxiety, cardiovascular stress, and psychological intensity
Cannabidiol	Caution	Cannabis can unpredictably intensify psychedelic effects and increase anxiety
Datura	Caution	Unpredictable compounding of hallucinogenic effects with anticholinergic delirium
Dichloropane	Caution	Increases anxiety, cardiovascular stress, and psychological intensity
Diphenhydramine	Caution	Unpredictable compounding of hallucinogenic effects with anticholinergic delirium
Ephedrine	Caution	Increases anxiety, cardiovascular stress, and psychological intensity
Harmala alkaloid	Caution	MAOIs dramatically potentiate psychedelics; drastically reduce dose and exercise extreme caution
Hexedrone	Caution	Increases anxiety, cardiovascular stress, and psychological intensity
Methcathinone	Caution	Increases anxiety, cardiovascular stress, and psychological intensity
Nicotine	Caution	Increases anxiety, cardiovascular stress, and psychological intensity
Oxiracetam	Caution	Increases anxiety, cardiovascular stress, and psychological intensity
Peganum harmala	Caution	MAOIs dramatically potentiate psychedelics; drastically reduce dose and exercise extreme caution
Phenylpiracetam	Caution	Increases anxiety, cardiovascular stress, and psychological intensity
Rhodiola Rosea	Caution	Increases anxiety, cardiovascular stress, and psychological intensity
Cannabis	Uncertain	—
1,3-Butanediol	Low Risk & Synergy	Cross-tolerance exists; effects compound
25E-NBOH	Low Risk & Synergy	Cross-tolerance exists; effects compound
2C-T	Low Risk & Synergy	Cross-tolerance exists; effects compound
2C-T-2	Low Risk & Synergy	Cross-tolerance exists; effects compound
2C-T-21	Low Risk & Synergy	Cross-tolerance exists; effects compound
2C-T-7	Low Risk & Synergy	Cross-tolerance exists; effects compound
3-Cl-PCP	Low Risk & Synergy	Produces unique synergistic effects; often combined
3-HO-PCE	Low Risk & Synergy	Produces unique synergistic effects; often combined
3-HO-PCP	Low Risk & Synergy	Produces unique synergistic effects; often combined
3-MeO-PCE	Low Risk & Synergy	Produces unique synergistic effects; often combined
3-MeO-PCMo	Low Risk & Synergy	Produces unique synergistic effects; often combined
3-MeO-PCP	Low Risk & Synergy	Produces unique synergistic effects; often combined
4-MeO-PCP	Low Risk & Synergy	Produces unique synergistic effects; often combined
Allylescaline	Low Risk & Synergy	Cross-tolerance exists; effects compound
Ayahuasca	Low Risk & Synergy	Cross-tolerance exists; effects compound
Deschloroketamine	Low Risk & Synergy	Produces unique synergistic effects; often combined
DET	Low Risk & Synergy	Cross-tolerance exists; effects compound
Diphenidine	Low Risk & Synergy	Produces unique synergistic effects; often combined
DiPT	Low Risk & Synergy	Cross-tolerance exists; effects compound
DOM	Low Risk & Synergy	Cross-tolerance exists; effects compound
DPT	Low Risk & Synergy	Cross-tolerance exists; effects compound
Efavirenz	Low Risk & Synergy	Cross-tolerance exists; effects compound
Ephenidine	Low Risk & Synergy	Produces unique synergistic effects; often combined
EPT	Low Risk & Synergy	Cross-tolerance exists; effects compound
HXE	Low Risk & Synergy	Produces unique synergistic effects; often combined
Ibogaine	Low Risk & Synergy	Cross-tolerance exists; effects compound
Inhalants	Low Risk & Synergy	Produces unique synergistic effects; often combined
Memantine	Low Risk & Synergy	Produces unique synergistic effects; often combined
MET	Low Risk & Synergy	Cross-tolerance exists; effects compound
Methallylescaline	Low Risk & Synergy	Cross-tolerance exists; effects compound
MiPT	Low Risk & Synergy	Cross-tolerance exists; effects compound
MPT	Low Risk & Synergy	Cross-tolerance exists; effects compound
MXiPr	Low Risk & Synergy	Produces unique synergistic effects; often combined
O-PCE	Low Risk & Synergy	Produces unique synergistic effects; often combined
PCE	Low Risk & Synergy	Produces unique synergistic effects; often combined
Psilocybin Mushrooms	Low Risk & Synergy	Cross-tolerance exists; effects compound
Lorazepam	Low Risk & Decrease	Depressants dull psychedelic effects; benzodiazepines are commonly used as trip-killers

Showing 60 key interactions out of 79 total.

Toxicity & Safety

Acute Toxicity

No formal human toxicological data exists. Based on structural class membership (substituted 4-hydroxy tryptamine) and accumulated community experience, acute physiological toxicity at typical psychedelic doses is presumed low. Shulgin's documentation did not identify acute toxicological concerns at the doses he explored (10–20 mg).

Physiological Profile

Standard sympathomimetic effects of serotonergic psychedelics apply: mydriasis, mild tachycardia, possible nausea during onset. The compound may produce more pronounced nausea than DMT analogs due to the altered serotonin receptor binding profile. Some users describe significant gastric discomfort during the onset phase.

The physical and sensory amplification characteristic of DiPT analogs can include heightened proprioception and altered tactile sensitivity, which is generally experienced as pleasurable but can be disorienting in unfamiliar contexts.

Psychological Risks

Anxiety — The rapid onset and intense bodily/sensory effects can generate anxiety, particularly in first-time users unfamiliar with the compound's distinct character.
Overstimulation — The stimulating, physical quality of 4-AcO-DiPT can combine with anxiety to produce an uncomfortable, agitated state.
Psychosis risk — Standard contraindication for personal or family history of psychotic disorders applies.

Drug Interactions

MAOIs — Potentiation; combination contraindicated.
Stimulants — Additive cardiovascular and CNS stimulation; increased anxiety risk.
Cannabis — Significant unpredictable intensity amplification.

Addiction Potential

not habit-forming

Overdose Information

Fatal overdose from 4-AcO-DiPT alone, at doses within the typical recreational range, is extremely unlikely based on the available evidence for classical psychedelics. The therapeutic index for most psychedelics is very wide.

However, psychological emergencies can occur and require appropriate response:

Severe anxiety, panic, or psychotic episodes
Dangerous behavior due to impaired reality testing
Self-harm in the context of a distressing experience

Emergency management: If someone is experiencing a severe adverse reaction, move them to a calm, quiet environment. Speak reassuringly. Do not restrain unless there is immediate danger. Benzodiazepines (if available and the person is conscious and able to swallow) can reduce acute anxiety. If psychotic symptoms, self-harm risk, or medical distress is present, seek emergency medical attention.Medical attention: Seek help immediately for seizures, extremely elevated body temperature, signs of serotonin syndrome (agitation, tremor, diarrhea, rapid heart rate), or if the substance consumed is uncertain.

Full	almost immediately after ingestion
Half	3 days
Zero	7 days

4-AcO-DiPT

Quick Dosage

Dosage

oral

Duration

oral

How It Feels

Subjective Effects

Physical Effects

Physical(13)

Tactile(1)

Cognitive & Perceptual Effects

Visual(6)

Pharmacology

Prodrug Hydrolysis

5-HT2A Agonism

Pharmacokinetics

The Short Duration Profile

Detection Methods

Urine Detection

Blood and Serum Detection

Standard Drug Panel Inclusion

Confirmatory Methods

Reagent Testing (Harm Reduction)

Interactions

History

Shulgin Documentation

Research Chemical Market

Contemporary Status

Harm Reduction

Obtain and Test

Dosing

Manage the Onset

Setting Considerations

Duration and Planning

Toxicity & Safety

Acute Toxicity

Physiological Profile

Psychological Risks

Drug Interactions

Addiction Potential

Overdose Information

Tolerance

Cross-tolerances

Legal Status

Experience Reports (2)

Tips (4)

See Also

References (4)

Frequently Asked Questions

Cognitive(9)

Auditory(1)